gemcitabine,paclitaxel
Not Tagged
['paclitaxel', 'gemcitabine', 'pancreatic']
validation of the pdacai signature in predicting relative benefit from frontline folfirinox (ffx) and gemcitabine/nab-paclitaxel (ga) for patients (pts) with metastatic pancreatic cancer (mpdac). visit our poster session #asco23 
Providing people with cancer & their oncologists with the best personalized and ranked #cancer treatment options through precision oncology. hope@perthera.com